InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,591.96
(
0.00%
)
US TECH 100
18,981.20
(
0.82%
)
Dow Jones
41,335.05
(
0.59%
)
Brent Oil
78.97
(
0.26%
)
Bitcoin
59,498.16
(
0.17%
)
Post# of 252990
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

apljack

Send PM Follow Ignore
Followers 6
Posts 703
Boards Moderated 0
Alias Born 09/23/2006

apljack

Re: exwannabe post# 45607

Monday, 04/23/2007 8:23:55 PM

Monday, April 23, 2007 8:23:55 PM

Post# of 252990
Well, NRMX is on MY short list if your quote from the statisticians is accurate. Given the nearly meaningless data-point changes necessary for statistical significance in Alzheimer's studies (CIBIC, CDR, and/or ADAS scores) and the huge numbers of subjects necessary to generate a powerful enough statistical paradigm, having your statistician tell you that your not going to make it is BAD news for clinical utility for the drug.

aj
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up